Publications by authors named "Hiroki Matui"
Acute Med Surg
February 2021
Article Synopsis
- The study aimed to determine the effectiveness of adding clindamycin to standard care for patients with invasive non-group A β-hemolytic infections, given that it is recommended for group A infections.
- Using a nationwide database from Japan, researchers conducted a retrospective cohort study analyzing data from 2010 to 2018 and compared outcomes between patients treated with and without clindamycin.
- The results indicated that there was no significant difference in in-hospital mortality rates between the clindamycin group (9.7%) and the control group (10.3%), suggesting that clindamycin does not improve outcomes for these infections.
